Nevada AG: Canada Rx imports "unworkable"
George Chanos, Attorney General of the US state of Nevada, says that state legislation bans the import of prescription drugs from Canada unless they have been approved by the Food and Drug Administration.
Following a request from Larry Pinson, executive secretary to the Nevada State Board of Pharmacy, AG Chanos analyzed state Senate Bill 5, which was enacted in a special session of the 2005 legislature to authorize the licensing of certain Canadian pharmacies to provide only "FDA-approved" prescription drugs by mail to Nevada residents.
AG Chanos has concluded that, "unfortunately," this prohibition means that few, if any, drugs sold from Canadian pharmacies can be legally imported into Nevada
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze